EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Eltrombopag directly activates BAK and induces apoptosis

Meng Chen, Lei Hu, Xuyuan Bao, Kaiqin Ye, Yunjian Li, Zhiyong Zhang, Scott H Kaufmann iD, Jun Xiao, Haiming Dai iD

Cell Death & Disease · 2023

DOI: 10.1038/s41419-023-05918-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Death & Disease, 2023. Verfasst von Meng Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Ch…. Hauptthemen laut MEDLINE: Fibroblasts, Apoptosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Anhui Provincial Key R&D Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small molecule direct BAK activators can potentially be used for the development of anti-cancer drugs or as tools to study BAK activation. The thrombopoietin receptor agonist eltrombopag (Eltro) inhibits BAX activation and BAX-mediated apoptosis. Here we report that, in contrast to its function as a BAX inhibitor, Eltro directly binds BAK but induces its activation in vitro. Moreover, Eltro induces or sensitizes BAK-dependent cell death in mouse embryonic fibroblasts (MEFs) and Jurkat cells. Chemical shift perturbation analysis by NMR indicates that Eltro binds to the BAK α4/α6/α7 groove to initiate BAK activation. Further molecular docking by HADDOCK suggests that several BAK residues, including R156, F157, and H164, play an important role in the interaction with Eltro. The introduction of an R156E mutation in the BAK α4/α6/α7 groove not only decreases Eltro binding and Eltro-induced BAK activation in vitro but also diminishes Eltro-induced apoptosis. Thus, our data suggest that Eltro directly induces BAK activation and BAK-dependent apoptosis, providing a starting point for the future development of more potent and selective direct BAK activators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsApoptosisAnimalsMiceMolecular Docking Simulationbcl-2-Associated X ProteinBenzoatesHydrazinesPyrazoles

Substanzen

bcl-2-Associated X ProteineltrombopagBenzoatesHydrazinesPyrazoles

Autor:innen und Institutionen

  • Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • University of Science and Technology of China, Hefei, 230026, China.
  • Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China.
  • School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China.
  • Department of Physics, University of Science and Technology of China, Hefei, 230026, China.
  • Division of Oncology Research, Mayo Clinic, Rochester, MN, 55905, USA.

ORCID-Profile: Scott H Kaufmann, Haiming Dai

Förderung

  • National Natural Science Foundation of China
  • Anhui Provincial Key R&D Program

Zitieren

APA

Chen, M., Hu, L., Bao, X., Ye, K., Li, Y., Zhang, Z., Kaufmann, S. H., Xiao, J., & Dai, H. (2023). Eltrombopag directly activates BAK and induces apoptosis. Cell Death & Disease. https://doi.org/10.1038/s41419-023-05918-6

Vancouver

Chen M, Hu L, Bao X, Ye K, Li Y, Zhang Z, et al. Eltrombopag directly activates BAK and induces apoptosis. Cell Death & Disease. 2023. doi:10.1038/s41419-023-05918-6

BibTeX
@article{Chen2023,
  author = {Chen, Meng and Hu, Lei and Bao, Xuyuan and Ye, Kaiqin and Li, Yunjian and Zhang, Zhiyong and Kaufmann, Scott H and Xiao, Jun and Dai, Haiming},
  title = {Eltrombopag directly activates BAK and induces apoptosis},
  journal = {Cell Death & Disease},
  year = {2023},
  doi = {10.1038/s41419-023-05918-6}
}
Kostenlos starten →